Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features.
- Published In:
- Journal of cutaneous pathology, 45(7), 539-544 (2018)
- Authors:
- Dolkar, Tsetan, Trinidad, Celestine M, Nelson, Kelly C, Amaria, Rodabe N, Nagarajan, Priyadharsini, Torres-Cabala, Carlos A, Ivan, Doina, Prieto, Victor G, Tetzlaff, Michael T, Curry, Jonathan L, Aung, Phyu P
- Database ID:
- RPEP-03649
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03649APA
Dolkar, Tsetan; Trinidad, Celestine M; Nelson, Kelly C; Amaria, Rodabe N; Nagarajan, Priyadharsini; Torres-Cabala, Carlos A; Ivan, Doina; Prieto, Victor G; Tetzlaff, Michael T; Curry, Jonathan L; Aung, Phyu P. (2018). Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features.. Journal of cutaneous pathology, 45(7), 539-544. https://doi.org/10.1111/cup.13262
MLA
Dolkar, Tsetan, et al. "Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features.." Journal of cutaneous pathology, 2018. https://doi.org/10.1111/cup.13262
RethinkPeptides
RethinkPeptides Research Database. "Dermatologic toxicity from novel therapy using antimicrobial..." RPEP-03649. Retrieved from https://rethinkpeptides.com/research/dolkar-2018-dermatologic-toxicity-from-novel
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.